Location History:
- Wilmette, IL (US) (2021)
- New York, NY (US) (2020 - 2024)
Company Filing History:
3 out of 5 
2 out of 2,489 
Years Active: 2020-2024
Title: Innovator Sara Cotter: Pioneering Treatments for Prader-Willi Syndrome
Introduction
Sara Cotter is an accomplished inventor based in New York, NY, who has made significant contributions to the medical field with her innovative approaches to treating Prader-Willi syndrome. With a total of three patents to her name, Sara's work focuses on advancing the understanding and management of this complex neurodevelopmental disorder.
Latest Patents
Among her most notable patents are:
1. **Methods of treating Prader-Willi syndrome** - This patent revolves around methods for regulating prohormone convertase (PC1) along with compounds and treatments that aim to increase PC1 levels, thereby providing new avenues for treating Prader-Willi Syndrome (PWS).
2. **Methods of treating Prader-Willi syndrome with carbetocin** - This patent describes stable aqueous compositions that include relatively high concentrations of carbetocin and a solubilizer and/or surface active agent. These innovative compositions are effective in managing Prader-Willi syndrome and demonstrate improved stability at room temperature and under stress conditions.
Career Highlights
Sara Cotter has had a dynamic career, working with esteemed organizations such as Levo Therapeutics, Inc., and Columbia University. Her time at these institutions has allowed her to collaborate with leading experts in the field while furthering her research and innovation in treatments for Prader-Willi syndrome.
Collaborations
Collaboration plays a key role in the advancement of her work. Among her notable colleagues are Lisa Cole Burnett and Dieter Egli, both of whom have contributed their expertise and knowledge to support her research initiatives.
Conclusion
Sara Cotter stands out as a remarkable inventor in the field of medical research, particularly for her groundbreaking work related to Prader-Willi syndrome. Her innovative patents not only enhance the understanding of this disorder but also open doors to more effective treatment options for affected individuals.